Is postoperative chemotherapy alone sufficient to treat young children with medulloblastoma?: Commentary

Nature Clinical Practice Oncology

Volumn 2, Issue 8, 2005, Pages 386-387

  Packer, Roger J ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Brain; Chemotheraphy; Children; Medulloblastoma; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; MAFOSFAMIDE; METHOTREXATE; VINCRISTINE;

BONE MARROW TOXICITY; CANCER LOCALIZATION; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESPONSE; EARLY DIAGNOSIS; FEVER; FOLLOW UP; HUMAN; INTELLIGENCE QUOTIENT; LEUKOENCEPHALOPATHY; MEDULLOBLASTOMA; METASTASIS; NEUROSURGERY; NEUROTOXICITY; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE CARE; PRIORITY JOURNAL; SHORT SURVEY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TUMOR CLASSIFICATION;

EID: 30944463435     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0245     Document Type: Short Survey

References (4)

1. Kuehl J et al. (1995) Delayed radiation therapy after postoperative chemotherapy in children less than 3 years of age with medulloblastoma: results of the trial HIT-SKK'87 and preliminary results of the pilot trial HIT-SKK'92. Med Pediatr Oncol 25 (Suppl): [abstract #250]
2. Sure U et al. (1995) Staging, scoring and grading of medulloblastoma. A post-operative prognosis predicting system based on the cases of a single institution. Acta Neurochir 132:59-65
3. Duffner PK et al. (1993) Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med 328: 1725-1731
4. Riva D et al. (2002) Intrathecal methotrexate affects cognitive function in children with medulloblastoma. Neurology 59:48-53